Management of gastro-oesophageal reflux disease in general practice

British Medical Journal

Volumn 322, Issue 7282, 2001, Pages 344-347

  Dent, J ^a   Jones, R ^b   Kahrilas, P ^c   Talley, N J ^d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

CANADA; DATA BASE; ESOPHAGITIS; EUROPE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTICE; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; UNITED STATES; WORKSHOP;

EID: 0035835413     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7282.344     Document Type: Review

References (30)

1. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
2. GERD in primary care. Comparison and development of European guidelines on gastroesophageal reflux disease
3. Diagnosis and treatment report of a meeting held in Paris, France on 21-22 January 1999. The jury of the consensus conference
4. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
5. The second Canadian gastroesophageal reflux disease consensus: Moving forward to new concepts
6. Gastroesophageal reflux disease
7. Gastro-oesophageal reflux disease
8. Treatment of gastrooesophageal reflux disease in adults
9. An evidence-based appraisal of reflux disease management - The Genval workshop report
10. Methodological aspects of evaluation of quality of life in upper gastrointestinal disease
11. The impact of gastroesophageal reflux disease on health-related quality of life
12. Functional gastroduodenal disorders
13. Quality of life and cost of therapy in reflux disease
14. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease
15. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms
16. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55?
17. The columnar-lined oesophagus, intestinal metaplasia, and Norman Barrett
18. Practice guidelines on the diagnosis, surveillance, and the therapy of Barrett's esophagus
19. The endoscopic assessment of oesophagitis: A progress report on observer agreement
20. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification
21. Omeprazole is more effective titan cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis
22. Erosive esophagitis: Outcome of repeated long-term maintenance treament with low dose omeprazole 10 mg or placebo
23. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efificacy, safety and influence on gastric mucosa
24. Heartburn treatment in primary care: Randomised, double blind study for eight weeks
25. A comparison of five maintenance therapies for reflux esophagitis
26. Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine
27. Management of patients with gastroesophageal reflux disease: A long-term follow-up study
28. Three to 45-year prospective study of prognostic indicators in gastroesophageal reflux disease
29. A randomized comparison between omeprazole and open anti-reflux disease: Report on 5 year follow up
30. Long-term management of gastro-oesophageal reflux disease with omepmzole or open anti-reflux surgery: Results of a prospective, randomised clinical trial